Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 43 CNY -4.04%
Market Cap: 5.1B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Acrobiosystems Co Ltd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acrobiosystems Co Ltd
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
Other Receivables
ÂĄ23.7m
CAGR 3-Years
171%
CAGR 5-Years
112%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Receivables
ÂĄ685.6m
CAGR 3-Years
55%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Other Receivables
ÂĄ121.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Receivables
ÂĄ92.2m
CAGR 3-Years
36%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other Receivables
ÂĄ185.2m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
21%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Receivables
ÂĄ8m
CAGR 3-Years
-23%
CAGR 5-Years
-34%
CAGR 10-Years
-25%
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
5.1B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
48.56 CNY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's Other Receivables?
Other Receivables
23.7m CNY

Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's Other Receivables amounts to 23.7m CNY.

What is Acrobiosystems Co Ltd's Other Receivables growth rate?
Other Receivables CAGR 5Y
112%

Over the last year, the Other Receivables growth was 225%. The average annual Other Receivables growth rates for Acrobiosystems Co Ltd have been 171% over the past three years , 112% over the past five years .

Back to Top